Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 207,000 | 202,000 |
| Marketable Securities | 2,672,000 | 2,154,000 |
| Receivables | 1,234,000 | 1,099,000 |
| Inventories | 737,000 | 764,000 |
| Income taxes - deferred | N/A | 234,000 |
| Other current assets | 553,000 | 424,000 |
| TOTAL | $5,403,000 | $4,877,000 |
| Non-Current Assets | ||
| PPE Net | 1,217,000 | 1,143,000 |
| Investments And Advances | 427,000 | 371,000 |
| Intangibles | 401,000 | 261,000 |
| Other Non-Current Assets | 397,000 | 159,000 |
| TOTAL | $2,442,000 | $1,934,000 |
| Total Assets | $7,845,000 | $6,811,000 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 291,000 | 324,000 |
| Accounts payable and accrued liabilities | 667,000 | 642,000 |
| Other current liabilities | 1,300,000 | 1,251,000 |
| TOTAL | $2,258,000 | $2,217,000 |
| Non-Current Liabilities | ||
| Long Term Debt | 121,000 | 137,000 |
| Other Non-Current Liabilities | 1,102,000 | 813,000 |
| TOTAL | $1,255,000 | $983,000 |
| Total Liabilities | $3,513,000 | $3,200,000 |
| Shareholders' Equity | ||
| Common Shares | 1,463,000 | 1,462,000 |
| Other shareholders' equity | 955,000 | 327,000 |
| TOTAL | $4,304,000 | $3,578,000 |
| Total Liabilities And Equity | $7,817,000 | $6,778,000 |